SPDR S&P PHARMACEUTICALS ETF (XPH) Institutional Ownership Changes & 13F Activity

SPDR S&P PHARMACEUTICALS ETF (XPH). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q3 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Bank Of America Corp, Wells Fargo & Company/Mn, Kingsview Wealth Management, Llc, Morgan Stanley, and Envestnet Asset Management Inc.

InstitutionTypeChange in sharesChange Position %SharesReported stock balancePortfolio quarterFiling date
Cx InstitutionalSell-865-10.5%7,352$478.00Q3 2026Oct 02, 2026
Envestnet Asset Management IncSell-221,822-100.0%0$0.00Q3 2026Sep 23, 2026
Envestnet Portfolio Solutions, Inc.Sell-180,521-100.0%0$0.00Q3 2026Sep 23, 2026
Corient Private Wealth LlcSell-3,401-100.0%0$0.00Q3 2026Aug 27, 2026
Kingsview Wealth Management, LlcSell-314,894-100.0%0$0.00Q3 2026Aug 19, 2026
Beacon Pointe Advisors, LlcSell-5,731-100.0%0$0.00Q3 2026Aug 18, 2026
Caitlin John, LlcSell-500-100.0%0$0.00Q3 2026Aug 17, 2026
Bank Of America CorpSell-1,015,894-100.0%0$0.00Q3 2026Aug 14, 2026
Wells Fargo & Company/MnSell-387,368-100.0%0$0.00Q3 2026Aug 14, 2026
Two Sigma Investments, LpSell-35,751-100.0%0$0.00Q3 2026Aug 14, 2026
Susquehanna International Group, LlpSell-32,012-100.0%0$0.00Q3 2026Aug 14, 2026
Mai Capital ManagementSell-31,119-100.0%0$0.00Q3 2026Aug 14, 2026
Gts Securities LlcSell-26,885-100.0%0$0.00Q3 2026Aug 14, 2026
Goldman Sachs Group IncSell-26,231-100.0%0$0.00Q3 2026Aug 14, 2026
Royal Bank Of CanadaSell-21,917-100.0%0$0.00Q3 2026Aug 14, 2026
Summittx Capital, L.P.Sell-11,745-100.0%0$0.00Q3 2026Aug 14, 2026
D. E. Shaw & Co., Inc.Sell-11,416-100.0%0$0.00Q3 2026Aug 14, 2026
Hrt Financial LpSell-8,348-100.0%0$0.00Q3 2026Aug 14, 2026
Jane Street Group, LlcSell-6,253-100.0%0$0.00Q3 2026Aug 14, 2026
Osaic Holdings, Inc.Sell-5,909-100.0%0$0.00Q3 2026Aug 14, 2026
Raymond James Financial IncSell-5,497-100.0%0$0.00Q3 2026Aug 14, 2026
Ameritas Advisory Services, LlcSell-4,939-100.0%0$0.00Q3 2026Aug 14, 2026
Lifeworks Advisors, LlcSell-3,794-100.0%0$0.00Q3 2026Aug 14, 2026
Jones Financial Companies LllpSell-2,308-100.0%0$0.00Q3 2026Aug 14, 2026
Federation Des Caisses Desjardins Du QuebecSell-400-100.0%0$0.00Q3 2026Aug 14, 2026
Barclays PlcSell-344-100.0%0$0.00Q3 2026Aug 14, 2026
Qube Research & Technologies LtdSell-230-100.0%0$0.00Q3 2026Aug 14, 2026
Medallion Wealth Advisors, LlcSell-150-100.0%0$0.00Q3 2026Aug 14, 2026
Ifg Advisory, LlcSell-121-100.0%0$0.00Q3 2026Aug 14, 2026
Morgan StanleySell-314,226-100.0%0$0.00Q3 2026Aug 13, 2026
Showing 30 of 87

Frequently asked questions about XPH activity

  • Which institutional owners are buying XPH?

    Institutional owners buying XPH include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in XPH activity?

    "Buy" means an investor increased their reported position in XPH compared to the prior reporting period. This reflects growing exposure to SPDR S&P PHARMACEUTICALS ETF (XPH) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in XPH increasing?

    Institutional interest in XPH can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.